Investment in Yourgene Health plc

RNS Number : 8129P

Intuitive Investments Group plc

22 February 2021

 

Intuitive Investments Group plc

Investment in  Yourgene Health plc

Intuitive Investments Group plc (AIM: IIG) ("IIG" or the "Company"), a closed-end investment company focussed on the life sciences sector, announces an investment of £248,765 to acquire 1,584,920 ordinary shares of Yourgene Health plc (AIM: YGEN) ("Yourgene") at an average price of 15.70 pence per share (the "Investment").

Yourgene is an international molecular diagnostics group which develops and commercialises genetic products and services. Yourgene works in partnership with global leaders in DNA technology to advance diagnostic science. 

Robert Naylor, CEO of IIG, has an investment predating IIG's investment, of 164,456 ordinary shares in Yourgene . Accordingly, Robert Naylor did not vote as a member of the investment team of IIG in approving the Investment.

The Investment in Yourgene is the Company's sixth investment following its IPO in mid-December 2020.

For further information, please contact:

Intuitive Investments Group plc	www.iigplc.com
David Evans, Executive Chairman Robert Naylor, CEO	Via Walbrook PR
Strand Hanson Limited - Nominated Adviser	[phone]
James Harris / James Dance / James Bellman
Turner Pope Investments (TPI) Ltd - Broker	[phone]
Andrew Thacker / Zoe Alexander
Walbrook PR Limited - Media & Investor Relations	[phone] or [e-mail]
Sam Allen / Paul McManus	[phone] / [phone]

About Intuitive Investments Group plc ( www.iigplc.com )

The Company is a newly established investing company, seeking to provide investors with exposure to a portfolio concentrating on fast growing and/or high potential Life Sciences businesses operating predominantly in the UK, continental Europe and the US, utilising the Board's experience and in particular that of the Chairman, David Evans, to seek to generate capital growth over the long term for shareholders.

 

END

 

 

MSCSELESFEFSEIE